SK bioscience Co.,Ltd. (KRX:302440)
South Korea · Delayed Price · Currency is KRW 36,300
+950 (2.69%)
Oct 16, 2026, 3:30 PM KST
SK bioscience Market Cap
SK bioscience has a market cap or net worth of 2.83 trillion as of October 16, 2026. It is the 6,346th most valuable company in the world and the 145th biggest in South Korea. Its market cap has decreased by 21.76% in one year.
Market Cap
2.83T
Enterprise Value
2.80T
Revenue
659.27B
Global Rank
Country Rank
#145 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since March 18, 2021, SK bioscience's market cap has decreased from 12.93T to 2.83T, a decrease of -78.09%. That is a compound annual growth rate of -23.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 2.83T | -25.03% |
| Dec 30, 2025 | 3.78T | -4.31% |
| Dec 30, 2024 | 3.95T | -28.57% |
| Dec 28, 2023 | 5.53T | -2.04% |
| Dec 29, 2022 | 5.64T | -67.21% |
| Dec 30, 2021 | 17.21T | 33.14% |
| Mar 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Epis Holdings | 7.58T |
| SK Biopharmaceuticals | 5.43T |
| HLB Co., Ltd. | 5.42T |
| LigaChem Biosciences | 2.31T |
| ABL Bio | 2.27T |
| Peptron | 2.06T |
| Voronoi | 2.05T |
| OliX Pharmaceuticals | 1.99T |